MGMC Intervention Group for Maternal Care Patterns

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Illinois at Chicago, Chicago, IL
Maternal Care Patterns+2 More
Melanated Group Midwifery Care - Behavioral
Eligibility
< 65
Female
What conditions do you have?
Select

Study Summary

This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.

Eligible Conditions

  • Maternal Care Patterns
  • Patient Engagement
  • Adverse Birth Outcomes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 6 Secondary · Reporting Duration: 1 year postpartum (T6)

1 year postpartum (T6)
Patient Engagement-Postnatal adequacy
12 months postpartum (T6)
Medical Referrals
12 months postpartum (T^)
Social Referrals
Birth (T3)
Patient Engagement-Prenatal Adequacy
Patient Engagement-Prenatal Adherence
Month 12
Mental Well Being
Patient Autonomy
Patient activation
Provider Trust
Month 2
Patient Satisfaction
Respectful Care

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Usual Care
1 of 2
MGMC Intervention Group
1 of 2
Active Control
Experimental Treatment

432 Total Participants · 2 Treatment Groups

Primary Treatment: MGMC Intervention Group · No Placebo Group · N/A

MGMC Intervention Group
Behavioral
Experimental Group · 1 Intervention: Melanated Group Midwifery Care · Intervention Types: Behavioral
Usual CareNoIntervention Group · 1 Intervention: Usual Care · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year postpartum (t6)

Trial Background

Prof. Kylea Laina Liese, Assistant Professor
Principal Investigator
University of Illinois at Chicago
Closest Location: University of Illinois at Chicago · Chicago, IL
Photo of Chicago  1Photo of Chicago  2Photo of Chicago  3
2000First Recorded Clinical Trial
1 TrialsResearching Maternal Care Patterns
262 CompletedClinical Trials

Eligibility Criteria

Age < 65 · Female Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be able to speak and understand English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.